CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 10,000 shares at $27.05 ($270,520)
- 144 Insider Sale of Securities
- 4 Grant or award Chief Legal Officer acquired 61,771 shares (grant or award)
- 4 Planned sale Director sold 46,012 shares at $27.95 ($1,285,851)
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Accounting Officer gave up 217 shares (to pay taxes)
- 4 Open-market sale SVP, Chief of Staff sold 11,538 shares at $27.82 ($320,987)
- 4 Planned sale Director sold 7,500 shares at $28.01 ($210,075)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes President and CEO gave up 73,788 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 15,695 shares (grant or award)
- 4 Grant or award Director acquired 15,695 shares (grant or award)
- 4 Grant or award Director acquired 15,695 shares (grant or award)
- 4 Grant or award Director acquired 15,695 shares (grant or award)
- 4 Grant or award Director acquired 15,695 shares (grant or award)
Page 11 of 104 · 2,077 filings